NEOGENOMICS LABORATORIES, INC. Data Breach Notification Letter — Free Case Review

NeoGenomics Laboratories, Inc. is a leading specialized oncology testing and genetic reference laboratory that provides comprehensive diagnostic, prognostic, and predictive testing services to oncologists, pathologists, hospital systems, and clinical research organizations. Because of its specialized role in cancer care and precision medicine, the company collects, processes, and maintains an extraordinary volume of highly sensitive information. This includes not only standard demographic details but also intricate genomic profiles, detailed pathology reports, tissue sample records, clinical histories, and health insurance information. The centralization of this deeply personal medical data makes NeoGenomics an essential hub in modern oncology, while simultaneously creating a massive digital repository of sensitive records that requires the highest standard of cybersecurity protection.

In 2026, NeoGenomics Laboratories reported a significant data security incident to the Illinois Attorney General, raising serious concerns among patients, healthcare providers, and legal advocates alike. While investigations into sophisticated cyberattacks often center on unauthorized access to centralized clinical databases, third-party vendor compromises, or ransomware deployments, incidents within the healthcare testing sector typically involve threat actors penetrating networks to extract vast archives of unencrypted patient files. In the context of a specialized reference laboratory, an intrusion can expose interconnected digital systems where patient specimens, diagnostic results, and administrative records are stored together, magnifying the scope of potential unauthorized data exfiltration.

The data compromised in incidents involving healthcare testing facilities typically includes full names, dates of birth, Social Security numbers, medical record numbers, health insurance details, and specific diagnostic or genetic test results. The exposure of this combination of data elements creates severe and lasting risks for affected individuals. Unlike a stolen credit card, which can be easily cancelled and replaced, genomic and medical data cannot be altered. When bad actors gain access to medical history alongside identifying details like Social Security numbers, victims face long-term threats of medical identity theft—where unauthorized parties obtain medical care or prescriptions using another person's identity—as well as sophisticated financial fraud, targeted phishing scams, and fraudulent insurance claims that can disrupt a victim's credit profile and access to care.

As a healthcare entity handling protected health information, NeoGenomics Laboratories was bound by strict legal and regulatory mandates under the Health Insurance Portability and Accountability Act (HIPAA), the Health Information Technology for Economic and Clinical Health (HITECH) Act, and applicable state consumer protection laws. These frameworks require covered entities and their business associates to implement robust administrative, physical, and technical safeguards to secure electronic protected health information. This includes maintaining continuous network monitoring, enforcing multi-factor authentication, conducting regular vulnerability assessments, and properly encrypting data both at rest and in transit. The occurrence of a data breach strongly suggests a potential failure or lapse in these mandatory security protocols, raising questions about whether the company met its legal duty to protect consumer privacy.

Receiving a data notification letter from NeoGenomics Laboratories serves as formal legal acknowledgment that your confidential information was compromised due to inadequate security measures. Under established legal principles, the receipt of such a notice provides affected individuals with the legal standing necessary to participate in a class action lawsuit aimed at holding the company accountable for its security failures. Importantly, victims are not required to prove that they have already suffered actual financial loss or identity theft to seek legal recourse; the increased risk of future harm and the invasion of privacy are sufficient grounds for action. Our firm investigates these matters on a contingency fee basis, meaning affected individuals pay no upfront costs or out-of-pocket legal fees, and we only recover compensation if a successful recovery is secured on your behalf.